Click here to access the analysis relating to the above mentioned product. To change brands early could prove to be costly.

ProPharma / PWR in association with AFT have reduced the price to pharmacy of Fenpaed effective immediately, (from $2.63 to $2.37 excluding GST) offering you a significant opportunity to increase your $ margin on this product.

On a high volume product this additional margin would be very helpful to you all.

We acknowledge there is to be a change in Pharmaceutical Schedule pricing from 1 May 2019 and we advise at that time we will reduce the price to match the Ibuprofen- Ethics pricing.

This window of opportunity is available to you now.

By supporting this and managing your stock correctly, you will be able to continue to purchase and dispense Fenpaed until 31 July 2019 or stocks are depleted – whichever comes first.

We are pleased to be able to make this opportunity available to you and thank you in anticipation of your ongoing support.

About The Author